Status:
COMPLETED
Effect of High-intensity Laser Acupuncture on Muscle Performance, Pain and Quality of Life in Low Back Pain
Lead Sponsor:
Cairo University
Collaborating Sponsors:
King Khalid University
Conditions:
Chronic Nonspecific Low-back Pain
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
To investigate the effect of high-intensity laser acupuncture on muscle performance, pain, and quality of life in patients with chronic nonspecific low back pain (CNLBP).
Detailed Description
Chronic non-specific low back pain (CNSLBP) is a persistent back pain that affects people of all ages and significantly impacts individuals' daily activities and quality of life. While various treatme...
Eligibility Criteria
Inclusion
- The patients had CNSLBP with age from 20 to 40 years from both genders.
- Patients will be referred from an orthopedist with diagnosis of chronic low back pain without underlying pathological causes.
- The patients with chronic nonspecific low back pain more than 3months. Minimum pain intensity of 30 mm on the visual analogue scale (VAS) for pain, which ranges from 0 to 100 mm.
- Patients with normal BMI ranges between 18.5:24.9 kg/m2.
- The study populations must be willing to participate in the study
Exclusion
- Neurological, infectious diseases and systemic illness such as rheumatologic diseases,systemic lupus erythematosus, diabetes mellitus type I or II.
- Psychiatric/mental deficit.
- Patients who had a previous surgical history (within 6 months) will also excluded.
- participation in other treatment within the previous 3 month.
- Pregnancy.
- History of spinal fracture, tumor, osteoporosis
- use of medication, such as corticosteroids, anticonvulsants, and antiinflammatory drugs that may affect the outcome of the study.
- prior history of adverse effects to physical stimulation therapy.
- significant physical or mental deficiencies preventing a clear understanding of the study procedure.
- spinal stenosis, thyroid dysfunctions, obesity, pace-maker.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06612918
Start Date
October 1 2024
End Date
March 31 2025
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Egypt
Giza, Egypt, 11251